Baird Financial Group
BNTX icon

Baird Financial Group’s BioNTech BNTX Stock Holding History

Baird Financial Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,448
Closed -$1.13M – 1777
2025
Q1 		$1.13M Sell
12,448
-6,141
-33% -$688K ﹤0.01% 1136
2024
Q4 		$2.12M Buy
18,589
+2,307
+14% +$263K ﹤0.01% 954
2024
Q3 		$1.93M Buy
16,282
+2,502
+18% +$230K ﹤0.01% 968
2024
Q2 		$1.11M Buy
13,780
+6,221
+82% +$569K ﹤0.01% 1133
2024
Q1 		$697K Buy
+7,559
New +$725K ﹤0.01% 1267
2021
Q4 		– Sell
-5,800
Closed -$1.58M – 1880
2021
Q3 		$1.58M Sell
5,800
-758
-12% -$241K ﹤0.01% 1025
2021
Q2 		$1.47M Buy
+6,558
New +$1.24M ﹤0.01% 1034

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baird Financial Group's BNTX Position: Q2 2025 in Review

Baird Financial Group sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 12,448 shares — an estimated $1.13M sold.

Baird Financial Group first reported a position in BNTX in Q2 2021 and held it in 7 quarters. The position peaked at $2.12M in Q4 2024. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Baird Financial Group reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Baird Financial Group sold 12,448 BioNTech shares in Q2 2025, an estimated $1.13M.
  • Baird Financial Group first reported a position in BioNTech in Q2 2021 and held it in 7 quarters.
  • Baird Financial Group's BioNTech position peaked at $2.12M in Q4 2024.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Baird Financial Group's 13F filing for Q2 2025, filed 13 Aug 2025.